loadpatents
name:-0.035728216171265
name:-0.031791925430298
name:-0.0014550685882568
Bhagwat; Shripad S. Patent Filings

Bhagwat; Shripad S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhagwat; Shripad S..The latest application filed is for "raf kinase modulator compounds and methods of use thereof".

Company Profile
2.31.28
  • Bhagwat; Shripad S. - San Diego CA
  • - San Diego CA US
  • Bhagwat; Shripad S. - Lake Bluff IL
  • Bhagwat; Shripad S. - Libertyville IL
  • Bhagwat; Shripad S. - Scotch Plains NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
RAF kinase modulator compounds and methods of use thereof
Grant 10,053,430 - Abraham , et al. August 21, 2
2018-08-21
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20170298029 - ABRAHAM; Sunny ;   et al.
2017-10-19
RAF kinase modulator compounds and methods of use thereof
Grant 9,730,937 - Abraham , et al. August 15, 2
2017-08-15
Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[- 2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
Grant 9,585,892 - Bhagwat , et al. March 7, 2
2017-03-07
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20160199375 - Abraham; Sunny ;   et al.
2016-07-14
RAF kinase modulator compounds and methods of use thereof
Grant 9,320,739 - Abraham , et al. April 26, 2
2016-04-26
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20150246042 - Abraham; Sunny ;   et al.
2015-09-03
Solid Forms Comprising N-(5-tert-butyl-isoxazol-3-yl)-n'-urea, Compositions Thereof, And Uses Therewith
App 20150238499 - Bhagwat; Shripad S. ;   et al.
2015-08-27
RAF kinase modulator compounds and methods of use thereof
Grant 8,969,587 - Abraham , et al. March 3, 2
2015-03-03
Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[- 2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
Grant 8,883,783 - Bhagwat , et al. November 11, 2
2014-11-11
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20140045868 - Abraham; Sunny ;   et al.
2014-02-13
RAF kinase modulator compounds and methods of use thereof
Grant 08618289 -
2013-12-31
RAF kinase modulator compounds and methods of use thereof
Grant 8,618,289 - Abraham , et al. December 31, 2
2013-12-31
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20110118245 - Abraham; Sunny ;   et al.
2011-05-19
Solid Forms Comprising N-(5-tert-butyl-isoxazol-3-yl)-n'-urea, Compositions Thereof, And Uses Therewith
App 20090131426 - Bhagwat; Shripad S. ;   et al.
2009-05-21
Indazole Compounds And Methods Of Use Thereof
App 20090099178 - Bhagwat; Shripad S. ;   et al.
2009-04-16
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
Grant 7,442,699 - Kois , et al. October 28, 2
2008-10-28
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
Grant 7,429,599 - Satoh , et al. September 30, 2
2008-09-30
Methods for treating inflammatory conditions or inhibiting JNK
Grant 7,335,676 - Bennett , et al. February 26, 2
2008-02-26
Compounds and methods for modulation of estrogen receptors
Grant 7,279,489 - Bhagwat , et al. October 9, 2
2007-10-09
Benzopyranone compounds, compositions thereof, and methods of treatment therewith
Grant 7,247,646 - McKie , et al. July 24, 2
2007-07-24
Methods of using indazole derivatives as JNK inhibitors
Grant 7,220,771 - Bhagwat , et al. May 22, 2
2007-05-22
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
Grant 7,211,594 - Bhagwat , et al. May 1, 2
2007-05-01
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
Grant 7,208,513 - Bhagwat , et al. April 24, 2
2007-04-24
Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds
App 20070060616 - Bennett; Brydon ;   et al.
2007-03-15
4-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7- -hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewith
App 20070015817 - McKie; Jeffrey A. ;   et al.
2007-01-18
Methods for treating or preventing acute myelogenous leukemia
App 20070004777 - Bhagwat; Shripad S.
2007-01-04
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
Grant 7,129,242 - Satoh , et al. October 31, 2
2006-10-31
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
Grant 7,122,544 - Kois , et al. October 17, 2
2006-10-17
Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto
Grant 7,119,114 - Bennett , et al. October 10, 2
2006-10-10
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
App 20060030576 - Kois; Adam ;   et al.
2006-02-09
Indazole compounds and methods of use thereof
App 20060004043 - Bhagwat; Shripad S. ;   et al.
2006-01-05
Substituted diaminopyrimidines
App 20050222186 - Baudler, Monika ;   et al.
2005-10-06
Benzopyranone compounds, compositions thereof, and methods of treatment therewith
App 20050137231 - McKie, Jeffrey A. ;   et al.
2005-06-23
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
Grant 6,897,231 - Bhagwat , et al. May 24, 2
2005-05-24
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
App 20050107457 - Bhagwat, Shripad S. ;   et al.
2005-05-19
Indazole compounds, compositions thereof and methods of treatment therewith
App 20050009876 - Bhagwat, Shripad S. ;   et al.
2005-01-13
Methods for treating inflammatory conditions or inhibiting JNK
App 20040176434 - Bennett, Brydon L. ;   et al.
2004-09-09
Methods for treating an inflammatory condition or inhibiting JNK
App 20040127536 - Bhagwat, Shripad S. ;   et al.
2004-07-01
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
App 20040106634 - Satoh, Yoshitaka ;   et al.
2004-06-03
Benzopyranone compounds, compositions thereof, and methods of treatment therewith
App 20040092572 - Renaud, Johanne ;   et al.
2004-05-13
Compounds and methods for modulation of estrogen receptors
App 20040082575 - Bhagwat, Shripad S. ;   et al.
2004-04-29
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
App 20040077877 - Bhagwat, Shripad S. ;   et al.
2004-04-22
Methods for treating inflammatory conditions or inhibiting JNK
App 20040072888 - Bennett, Brydon L. ;   et al.
2004-04-15
Compounds and methods for modulation of estrogen receptors
Grant 6,686,351 - Bhagwat , et al. February 3, 2
2004-02-03
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
App 20030220330 - Yoshitaka, Satoh ;   et al.
2003-11-27
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
App 20030203926 - Kois, Adam ;   et al.
2003-10-30
Benzopyrazone compounds, compositions thereof, and methods of treatment therewith
Grant 6,620,838 - McKie , et al. September 16, 2
2003-09-16
Compounds and methods for modulation of estrogen receptors
Grant 6,593,322 - Bhagwat , et al. July 15, 2
2003-07-15
Compounds and methods for modulation of estrogen receptors
App 20030087901 - Bhagwat, Shripad S. ;   et al.
2003-05-08
Compounds and methods for modulation of estrogen receptors
Grant 6,436,923 - Bhagwat , et al. August 20, 2
2002-08-20
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
App 20020103229 - Bhagwat, Shripad S. ;   et al.
2002-08-01
Compounds and methods for modulation of estrogen receptors
Grant 6,331,562 - Bhagwat , et al. December 18, 2
2001-12-18
Compounds and methods for modulation of estrogen receptors
Grant 6,291,456 - Stein , et al. September 18, 2
2001-09-18
5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
Grant 6,030,969 - Bhagwat , et al. February 29, 2
2000-02-29
Cyclic hydrazine compounds
Grant 5,670,497 - Bold , et al. September 23, 1
1997-09-23
Heterocyclic substituted cyclopentane compounds
Grant 5,665,721 - Bhagwat , et al. September 9, 1
1997-09-09
(Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
Grant 5,025,025 - Bhagwat , et al. June 18, 1
1991-06-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed